Location History:
- Indianapolis, IN (US) (1998)
- Carmel, IN (US) (2002 - 2003)
Company Filing History:
Years Active: 1998-2003
Title: August Masaru Watanabe: Innovator in Alzheimer's Disease Treatment
Introduction
August Masaru Watanabe is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer's disease. With a total of 3 patents to his name, Watanabe's work is recognized for its potential impact on healthcare.
Latest Patents
Watanabe's latest patents focus on innovative methods for preventing and treating Alzheimer's disease. One of his patents discloses a method for the prevention and treatment of Alzheimer's disease by administering an effective amount of a substituted tricyclic sPLA inhibitor to individuals in need. Another patent outlines a method of treating mammals, including humans, who are susceptible to Alzheimer's disease. This method aims to prevent or delay the onset of the disease by administering a prophylactically effective amount of 1H-indole-3-glycoxyamide sPLA inhibitor or its pharmaceutically acceptable derivatives.
Career Highlights
Watanabe is currently employed at Eli Lilly and Company, a leading pharmaceutical company known for its commitment to innovation in healthcare. His work at Eli Lilly has allowed him to focus on groundbreaking research that addresses critical health issues.
Collaborations
Throughout his career, Watanabe has collaborated with esteemed colleagues such as Thomas F Bumol and Mitchell I Steinberg. These collaborations have further enriched his research and contributed to the advancement of treatments for Alzheimer's disease.
Conclusion
August Masaru Watanabe is a distinguished inventor whose work in Alzheimer's disease treatment showcases his dedication to improving human health. His innovative patents and collaborations highlight the importance of research in finding effective solutions for complex medical challenges.